POET

POET

Biotechnology Research

Sioux Falls, South Dakota 26,968 followers

For almost 40 years, we've been changing the world through sustainable, plant-based biofuels & bioproducts.

Über uns

At POET, we are changing the world for the better while leaving a legacy that promotes health and sustainability through renewable biofuels and bioproducts. We believe in creativity from common sense. We believe the solution to our nation's growing energy crises is not some far-flung work of science fiction. It's the domestic energy we're producing today. The people of POET are currently replacing millions of barrels of imported oil every year with clean, renewable energy, all while pumping billions of dollars back into the American economy. In our three-plus decades on the job, POET has developed an unmatched record in technology, reliability, and efficiency. That's a legacy we intend to pass on. And every day we keep building on it. Today, we have a network of 34 plants in eight states and produce more than 3 billion gallons of biofuels annually. More important than volume is the efficiency with which we produce our products. POET provides turnkey development, design, engineering, construction, management and marketing services for our plant network. Our facilities are the most successful and profitable in the industry. Our technologies were developed and refined through years of hard work and collaboration with leaders in clean technology, biochemistry and animal nutrition. As a result, we reap more value from a bushel of corn than anyone. In addition to biofuels, we've perfected the leading brand of premium dried distillers grains with solubles on the market, Dakota Gold®.

Website
http://poet.com
Industrie
Biotechnology Research
Größe des Unternehmens
1.001-5.000 Mitarbeiter
Hauptsitz
Sioux Falls, South Dakota
Typ
In Privatbesitz
Gegründet
1987
Spezialitäten
food and cellulosic ethanol

Standorte

Employees at POET

Aktualisierungen

Ähnliche Seiten

Jobs durchsuchen

Finanzierung

POET 3 total rounds

Letzte Runde

Serie unbekannt

US$ 53.8M

Siehe mehr Informationen auf crunchbase